These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Randomized trial of erhuangfang for relapsing multiple sclerosis. Zhou L; Fan Y Neurol Res; 2015 Jul; 37(7):633-7. PubMed ID: 25668581 [TBL] [Abstract][Full Text] [Related]
23. Axonal injury and overall tissue loss are not related in primary progressive multiple sclerosis. Rovaris M; Gallo A; Falini A; Benedetti B; Rossi P; Comola M; Scotti G; Comi G; Filippi M Arch Neurol; 2005 Jun; 62(6):898-902. PubMed ID: 15956160 [TBL] [Abstract][Full Text] [Related]
24. Assessing brain connectivity at rest is clinically relevant in early multiple sclerosis. Faivre A; Rico A; Zaaraoui W; Crespy L; Reuter F; Wybrecht D; Soulier E; Malikova I; Confort-Gouny S; Cozzone PJ; Pelletier J; Ranjeva JP; Audoin B Mult Scler; 2012 Sep; 18(9):1251-8. PubMed ID: 22307385 [TBL] [Abstract][Full Text] [Related]
25. [Differences in the spectroscopy of the lesions of the remitting relapsing form of multiple sclerosis shown by magnetic resonance]. Martínez-Bisbal MC; Celda B; Martí-Bonmat L; Casanova-Estruch B; Coret-Ferrer F Rev Neurol; 2002 May 1-15; 34(9):807-12. PubMed ID: 12134339 [TBL] [Abstract][Full Text] [Related]
26. Simvastatin treatment in patients with relapsing-remitting multiple sclerosis receiving interferon beta 1a: a double-blind randomized controlled trial. Togha M; Karvigh SA; Nabavi M; Moghadam NB; Harirchian MH; Sahraian MA; Enzevaei A; Nourian A; Ghanaati H; Firouznia K; Jannati A; Shekiba M Mult Scler; 2010 Jul; 16(7):848-54. PubMed ID: 20488825 [TBL] [Abstract][Full Text] [Related]
27. Evidence of Wallerian degeneration in normal appearing white matter in the early stages of relapsing-remitting multiple sclerosis: a HMRS study. Casanova B; Martínez-Bisbal MC; Valero C; Celda B; Martí-Bonmatí L; Pascual A; Landente L; Coret F J Neurol; 2003 Jan; 250(1):22-8. PubMed ID: 12527988 [TBL] [Abstract][Full Text] [Related]
28. [Clinical assessment of the course of relapsing-remitting multiple sclerosis in patients treated with interferon beta]. Pokryszko-Dragan A; Bilińska M; Gruszka E; Dubik-Jezierzańska M Pol Merkur Lekarski; 2005 Nov; 19(113):654-8. PubMed ID: 16498805 [TBL] [Abstract][Full Text] [Related]
29. Correlation of global N-acetyl aspartate with cognitive impairment in multiple sclerosis. Mathiesen HK; Jonsson A; Tscherning T; Hanson LG; Andresen J; Blinkenberg M; Paulson OB; Sorensen PS Arch Neurol; 2006 Apr; 63(4):533-6. PubMed ID: 16606765 [TBL] [Abstract][Full Text] [Related]
30. [Total brain T2-hyperintense lesion-volume and the axonal damage in the normal-appearing white matter of brainstem in early lapsing-remitting multiple sclerosis]. Pascual-Lozano AM; Martínez-Bisbal MC; Boscá-Blasco I; Valero-Merino C; Coret-Ferrer F; Martí-Bonmatí L; Martínez-Granados B; Celda B; Casanova-Estruch B Rev Neurol; 2007 Oct 16-31; 45(8):468-73. PubMed ID: 17948212 [TBL] [Abstract][Full Text] [Related]
31. Patients' stratification and correlation of brain magnetic resonance imaging parameters with disability progression in multiple sclerosis. Vaneckova M; Seidl Z; Krasensky J; Havrdova E; Horakova D; Dolezal O; Burgetova A; Masek M Eur Neurol; 2009; 61(5):278-84. PubMed ID: 19295214 [TBL] [Abstract][Full Text] [Related]
32. Multiple sclerosis: hyperintense lesions in the brain on nonenhanced T1-weighted MR images evidenced as areas of T1 shortening. Janardhan V; Suri S; Bakshi R Radiology; 2007 Sep; 244(3):823-31. PubMed ID: 17690319 [TBL] [Abstract][Full Text] [Related]
33. Combination of CSF N-acetylaspartate and neurofilaments in multiple sclerosis. Teunissen CE; Iacobaeus E; Khademi M; Brundin L; Norgren N; Koel-Simmelink MJ; Schepens M; Bouwman F; Twaalfhoven HA; Blom HJ; Jakobs C; Dijkstra CD Neurology; 2009 Apr; 72(15):1322-9. PubMed ID: 19365053 [TBL] [Abstract][Full Text] [Related]
34. Diffusion tensor fractional anisotropy of the normal-appearing seven segments of the corpus callosum in healthy adults and relapsing-remitting multiple sclerosis patients. Hasan KM; Gupta RK; Santos RM; Wolinsky JS; Narayana PA J Magn Reson Imaging; 2005 Jun; 21(6):735-43. PubMed ID: 15906348 [TBL] [Abstract][Full Text] [Related]
35. Influence of apolipoprotein E epsilon4 genotype on brain tissue integrity in relapsing-remitting multiple sclerosis. De Stefano N; Bartolozzi ML; Nacmias B; Zipoli V; Mortilla M; Guidi L; Siracusa G; Sorbi S; Federico A; Amato MP Arch Neurol; 2004 Apr; 61(4):536-40. PubMed ID: 15096402 [TBL] [Abstract][Full Text] [Related]
36. Global N-acetylaspartate declines even in benign multiple sclerosis. Rigotti DJ; Gonen O; Grossman RI; Babb JS; Falini A; Benedetti B; Filippi M AJNR Am J Neuroradiol; 2011 Jan; 32(1):204-9. PubMed ID: 20966065 [TBL] [Abstract][Full Text] [Related]
37. Preliminary evidence for neuronal damage in cortical grey matter and normal appearing white matter in short duration relapsing-remitting multiple sclerosis: a quantitative MR spectroscopic imaging study. Kapeller P; McLean MA; Griffin CM; Chard D; Parker GJ; Barker GJ; Thompson AJ; Miller DH J Neurol; 2001 Feb; 248(2):131-8. PubMed ID: 11284131 [TBL] [Abstract][Full Text] [Related]
38. Serial 1H-MRS in relapsing-remitting multiple sclerosis: effects of interferon-beta therapy on absolute metabolite concentrations. Schubert F; Seifert F; Elster C; Link A; Walzel M; Mientus S; Haas J; Rinneberg H MAGMA; 2002 Jun; 14(3):213-22. PubMed ID: 12098564 [TBL] [Abstract][Full Text] [Related]
40. Whole-brain N-acetylaspartate spectroscopy and diffusion tensor imaging in patients with newly diagnosed gliomas: a preliminary study. Inglese M; Brown S; Johnson G; Law M; Knopp E; Gonen O AJNR Am J Neuroradiol; 2006; 27(10):2137-40. PubMed ID: 17110683 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]